<DOC>
	<DOCNO>NCT02231294</DOCNO>
	<brief_summary>Documentation effect SIFROL® tremor depression well tolerability ambulatory patient suffer idiopathic Parkinson 's disease routine condition</brief_summary>
	<brief_title>The Effect Sifrol® Tremor Depression Patients With Idiopathic Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>Patients idiopathic Parkinson 's disease tremor and/or depression require therapy Sifrol® change therapy Sifro®l medication neuroleptic allow observed study Patients meet one general specific contraindication mention Summary Product Characteristics ( SPC ) Sifrol® Patients treatment neuroleptic observe study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>